Real-World Experiences with VMAT2 Inhibitors in Pediatric Hyperkinetic Movement Disorders
{{output}}
Background: Vesicular monoamine transporter 2 (VMAT2) inhibitors are often prescribed for the treatment of hyperkinetic movement disorders such as tics, stereotypy, tardive dyskinesia and chorea. These dopamine depleters have bee... ...
